Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

31
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
31

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chronological ageing and ovarian reserve in MS: insights from anti-Müllerian hormone and disability progression.

Journal of neurology, neurosurgery, and psychiatry·2026
Same author

Redefining Multiple Sclerosis: Toward a Biologically Driven Diagnosis.

Neurology·2026
Same author

Spider-MS: an individualized polyhedral prediction of multiple sclerosis prognosis.

Brain : a journal of neurology·2026
Same author

An automated quantitative report for multiple sclerosis using only 3D T2-fluid-attenuated inversion recovery MRI.

Neuroradiology·2026
Same author

Idiopathic Normal Pressure Hydrocephalus: A Comprehensive Review.

Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes·2026
Same author

Rethinking prognosis in multiple sclerosis: a multiaxial perspective.

Nature reviews. Neurology·2026
Same journal

Factors Associated With Disability Improvement and Worsening Independent of Attacks in Patients With AQP4-IgG+ NMOSD and MOGAD: A Multicenter Cohort Study.

Neurology·2026
Same journal

Cost-Effectiveness of Intracranial Aneurysm Screening: A Systematic Review.

Neurology·2026
Same journal

Rare Eating Epilepsy: Co-Occurrence of Focal Cortical Dysplasia and Gray Matter Heterotopia.

Neurology·2026
Same journal

Spatiotemporal Associations Between Cortical Microinfarcts and Cortical Superficial Siderosis in Cerebral Amyloid Angiopathy.

Neurology·2026
Same journal

Blood-Brain Barrier Disruption Before Interhospital Transfer for Thrombectomy and Clinical Outcome.

Neurology·2026
Same journal

At Death's Door: Cytosolic Dopamine in Patients With Parkinson Disease.

Neurology·2026
See all related articles

Related Experiment Video

Updated: May 6, 2026

Simple and Efficient Production and Purification of Mouse Myelin Oligodendrocyte Glycoprotein for Experimental Autoimmune Encephalomyelitis Studies
10:47

Simple and Efficient Production and Purification of Mouse Myelin Oligodendrocyte Glycoprotein for Experimental Autoimmune Encephalomyelitis Studies

Published on: October 27, 2016

11.1K

Deep Learning Modeling to Differentiate Multiple Sclerosis From MOG Antibody-Associated Disease.

Rosa Cortese1, Francesco Sforazzini2, Giordano Gentile1,2

  • 1Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy.

Neurology
|September 4, 2025
PubMed
Summary
This summary is machine-generated.

A new deep learning model and a clinical/MRI algorithm accurately distinguish myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) from multiple sclerosis (MS). Combining both approaches improved diagnostic accuracy, aiding in differentiating these neurological conditions.

More Related Videos

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
05:44

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice

Published on: October 13, 2023

1.6K
Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research
05:55

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research

Published on: December 1, 2023

965

Related Experiment Videos

Last Updated: May 6, 2026

Simple and Efficient Production and Purification of Mouse Myelin Oligodendrocyte Glycoprotein for Experimental Autoimmune Encephalomyelitis Studies
10:47

Simple and Efficient Production and Purification of Mouse Myelin Oligodendrocyte Glycoprotein for Experimental Autoimmune Encephalomyelitis Studies

Published on: October 27, 2016

11.1K
Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
05:44

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice

Published on: October 13, 2023

1.6K
Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research
05:55

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research

Published on: December 1, 2023

965

Area of Science:

  • Neurology
  • Radiology
  • Artificial Intelligence

Background:

  • Multiple sclerosis (MS) is a common adult neurological disorder, whereas myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is rare.
  • Distinguishing MOGAD from MS is crucial for appropriate treatment, as their management differs significantly.
  • Previous machine-learning models showed promise but required further validation.

Purpose of the Study:

  • To validate a clinical/MRI algorithm for differentiating MS from MOGAD.
  • To develop and evaluate a deep learning (DL) model for the same diagnostic task.
  • To assess the combined performance of both models and identify key differentiating imaging features using probability attention maps (PAMs).

Main Methods:

  • A multicenter retrospective study involving 406 MRI scans from adults with MS and MOGAD.
  • Performance evaluation of a pre-existing clinical/MRI algorithm on a validation dataset.
  • Development and testing of a ResNet-10 convolutional neural network-based DL classifier on independent datasets.
  • Generation of PAMs to visualize and quantify differentiating brain regions.

Main Results:

  • The clinical/MRI algorithm achieved 75% accuracy, 96% sensitivity, and 56% specificity in the validation cohort.
  • The DL model demonstrated 70% accuracy, 67% sensitivity, and 73% specificity in the validation cohort.
  • Combining both models yielded 86% accuracy, 84% sensitivity, and 89% specificity.
  • PAMs highlighted distinct lesion patterns, with corpus callosum, precentral gyrus, thalamus, and cingulate cortex differentiating MS, while the brainstem, hippocampus, and parahippocampal gyrus indicated MOGAD.

Conclusions:

  • Both the clinical/MRI algorithm and the DL model are effective in distinguishing MS from MOGAD.
  • The models have complementary strengths, with the clinical/MRI algorithm showing higher sensitivity and the DL model higher specificity.
  • The combination of both approaches significantly enhances diagnostic accuracy.
  • PAMs provide valuable insights into the distinct neuropathological patterns of MS and MOGAD, aiding differential diagnosis.